Status:
COMPLETED
Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia.
Lead Sponsor:
Medical University of South Carolina
Conditions:
Cesarean Section
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to determine the ideal dose of spinal morphine for use in Cesarean section. Spinal anesthesia (single injection in the lower back to numb patients from the waist down) is ...
Eligibility Criteria
Inclusion
- any parturient 18 years of age or older
- undergoing elective cesarean delivery under spinal anesthesia
- able to consent to the study and participate in the follow-up.
Exclusion
- any known allergy to morphine
- general anesthesia
- urgent or emergent cases
- any bleeding diathesis or other coagulopathy
- known G6PD deficiency
- any known liver disease
- known alcohol abuse or dependence
- HELLP syndrome
- thrombocytopenia or known platelet dysfunction
- history or active gastrointestinal bleeding
- acute kidney injury or chronic renal insufficiency
- contraindication/refusal to spinal anesthestic
- chronic pain
- chronic narcotic use
- illicit drug use
- allergy to any study related medications
Key Trial Info
Start Date :
January 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2023
Estimated Enrollment :
229 Patients enrolled
Trial Details
Trial ID
NCT03427463
Start Date
January 16 2018
End Date
August 3 2023
Last Update
December 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425